(Q48565649)

12 February 2018

title

Oxytocin regulates changes of extracellular glutamate and GABA levels induced by methamphetamine in the mouse brain. (English)

1 reference

12 February 2018

1 reference

Jia Qi

1

1 reference

12 February 2018

Wen-Yan Han

2

1 reference

12 February 2018

Jing-Yu Yang

3

1 reference

12 February 2018

Li-Hui Wang

4

1 reference

12 February 2018

Ying-Xu Dong

5

1 reference

12 February 2018

Fang Wang

6

1 reference

12 February 2018

Ming Song

7

1 reference

12 February 2018

Chun-Fu Wu

8

1 reference

12 February 2018

publication date

16 April 2012

1 reference

12 February 2018

published in

Addiction Biology

1 reference

12 February 2018

volume

17

1 reference

12 February 2018

issue

4

1 reference

12 February 2018

page(s)

758-769

1 reference

12 February 2018

Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Extracellular amino acid levels in the paraventricular nucleus and the central amygdala in high- and low-anxiety dams rats during maternal aggression: regulation by oxytocin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') using a drug discrimination paradigm in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

A review of the clinical pharmacology of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Release of oxytocin in the rat central amygdala modulates stress-coping behavior and the release of excitatory amino acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

GABA selectively controls the secretory activity of oxytocin neurons in the rat supraoptic nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Pharmacological characteristics and anatomical distribution of [3H]oxytocin-binding sites in the Wistar rat brain studied by autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

NAN-190, a possible specific antagonist for methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Lesions of the medial prefrontal cortex prevent the acquisition but not reinstatement of morphine-induced conditioned place preference in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Morphine decreases extracellular levels of glutamate in the anterior cingulate cortex: an in vivo microdialysis study in freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Pseudoginsenoside-F11 decreases morphine-induced behavioral sensitization and extracellular glutamate levels in the medial prefrontal cortex in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Acute cocaine treatment decreases oxytocin levels in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

The role of oxytocin-dopamine interactions in cocaine-induced locomotor hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Beta-endorphin tolerance is inhibited by oxytocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Methamphetamine toxicity and messengers of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Oxytocin blocks the development of heroin-fentanyl cross-tolerance in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Thyroid hormone regulation of N-methyl-D-aspartic acid receptor subunit mRNA expression in adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

GABAergic mediation of stress-induced secretion of corticosterone and oxytocin, but not prolactin, by the hypothalamic paraventricular nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

RV09, a novel resveratrol analogue, inhibits NO and TNF-alpha production by LPS-activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Dorsal, but not ventral, hippocampal lesions disrupt cocaine place conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

NMDA receptor subunits: function and pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Local hippocampal methamphetamine-induced reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Oxytocin mediates stress-induced analgesia in adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Oxytocin as a potential mediator and modulator of drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Selective attenuation of cocaine-induced stereotyped behaviour by oxytocin: putative role of basal forebrain target sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Role of oxytocin in the neuroadaptation to drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Functions of glutamate transporters in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Inhibitory role of oxytocin in psychostimulant-induced psychological dependence and its effects on dopaminergic and glutaminergic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

Oxytocin receptor agonists enhance inhibitory synaptic transmission in the rat hippocampus by activating interneurons in stratum pyramidale

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2012.00439.X

10.1111/J.1369-1600.2012.00439.X

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018